Novel pyrazole compounds for pharmacological discrimination between receptor‐operated and store‐operated Ca 2+ entry pathways

Abstract

Background and purpose Pyrazole derivatives have recently been suggested as selective blockers of transient receptor potential cation ( TRPC ) channels but their ability to distinguish between the TRPC and O rai pore complexes is ill‐defined. This study was designed to characterize a series of pyrazole derivatives in terms of TRPC / O rai selectivity and to delineate consequences of selective suppression of these pathways for mast cell activation. Experimental approach Pyrazoles were generated by microwave‐assisted synthesis and tested for effects on Ca 2+ entry by F ura‐2 imaging and membrane currents by patch‐clamp recording. Experiments were performed in HEK 293 cells overexpressing TRPC 3 and in RBL ‐2 H 3 mast cells, which express classical store‐operated Ca 2+ entry mediated by O rai channels. The consequences of inhibitory effects on Ca 2+ signalling in RBL ‐2 H 3 cells were investigated at the level of both degranulation and nuclear factor of activated T‐cells activation. Key Results P yr3, a previously suggested selective inhibitor of TRPC 3, inhibited Orai1‐ and TRPC 3‐mediated Ca 2+ entry and currents as well as mast cell activation with similar potency. By contrast, P yr6 exhibited a 37‐fold higher potency to inhibit O rai1‐mediated Ca 2+ entry as compared with TRPC 3‐mediated Ca 2+ entry and potently suppressed mast cell activation. The novel pyrazole P yr10 displayed substantial selectivity for TRPC 3‐mediated responses (18‐fold) and the selective block of TRPC 3 channels by P yr10 barely affected mast cell activation. Conclusions and Implications The pyrazole derivatives P yr6 and P yr10 are able to distinguish between TRPC and O rai‐mediated Ca 2+ entry and may serve as useful tools for the analysis of cellular functions of the underlying Ca 2+ channels.

Shown for reading. Its publisher allows quoting it, not republishing it.

Cited by papers we hold 4

• TRPC3 and NALCN channels drive pacemaking in substantia nigra dopaminergic neurons · 2021
  Not checked
• Transient Receptor Potential Canonical (TRPC) Channels: Then and Now · 2020
  No notice
• MICU1 drives glycolysis and chemoresistance in ovarian cancer · 2017
  No notice
• Transient receptor potential canonical type 3 channels control the vascular contractility of mouse mesenteric arteries. · 2014
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.